Chengdu Essay
Release time:
2020-12-22
Chengdu Essay
It is clearly winter. Chengdu seems to be still in late autumn. Standing on the street and looking around, there are a row of ginkgo trees, golden trees all over the ground, and the wind is passing by, rustling.
If you use a metaphor, Luoyang's winter is a broadsword with a ring head, which is deadly. Jinhua's winter is a boning knife, which is wet, cold and cold, and no matter how many clothes you wear, you can't stop it from drilling in. Chengdu's winter is not easy to evaluate. After all, I am just a tourist, perhaps because I am in a basin surrounded by mountains, and I always feel a beat slower than other people's winter, it's lazy hamster winter.
To tell the truth, winter is really not a good time to wander around. It is suitable to lie in bed, wrap the quilt tightly and doze off. When you wake up, you will not get up. You will drill hard into the quilt until your mother stands on the edge of the bed with a feather duster. Chengdu people don't seem to care at all. Since the first ray of sunshine hit the glass in the morning, the whole city has come to life. It is not until two or three o'clock in the morning that it calms down. Hot pot, string, barbecue, bar, eat, drink and have fun. Housing prices in Chengdu are not high, and consumption is not high. Young people living in Chengdu always have a variety of entertainment life, running tirelessly at night. Even when I woke up at three or four o'clock in the morning to drink water, I could hear the little couple next door laughing and chatting.
reminds me of 18 or 9 years old, that's really good!
At the age of 18 or 9, it is like a sexy and strong wild horse. When you try to grasp its reins, it twists its head and runs wildly on the grassland. When you want to give up, it runs back and stands by looking at you, tempting you, inciting you, making you itchy and helpless. At that time, I did what I wanted to do, because I didn't have anything, so I was not afraid of anything. I didn't want to protect anyone or anything. I didn't care about anything in my heart. Everything I did was like a bullfight, and I rushed forward. When chatting with friends, I always joked: "The youth of eighteen or nineteen is really young, and the youth of our twenties is fake youth. The difference is that we do what we want to do when we are eighteen or nineteen years old, and we can do whatever we want in our twenties."
In short, the time has passed. You can't catch up with it if you want. You can only see a figure in front of you, twist your ass and run away. Although I have already resigned myself to my fate, when I was eating spicy rabbit head, eating hot pot and rolling a string, the small fart child at the next table called you "uncle", and my heart was still hit hard. A table of delicious food was smashed and smashed, but I lost my taste.
How did you get to be an uncle?! (wang junxiao)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page